These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 8129666

  • 21. Effect of topical ophthalmic dorzolamide(2%)-timolol(0.5%) solution and ointment on intraocular pressure in normal horses.
    Tofflemire KL, Whitley EM, Flinn AM, Dufour VL, Ben-Shlomo G, Allbaugh RA, Griggs AN, Peterson CS, Whitley DR.
    Vet Ophthalmol; 2015 Nov; 18(6):457-61. PubMed ID: 25522663
    [Abstract] [Full Text] [Related]

  • 22. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
    Plummer CE, MacKay EO, Gelatt KN.
    Vet Ophthalmol; 2006 Nov; 9(4):245-9. PubMed ID: 16771760
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
    Wang RF, Gagliuso DJ, Mittag TW, Podos SM.
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
    [Abstract] [Full Text] [Related]

  • 25. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R, Queiroz CF, Santos LC, Avila MP, Magacho L.
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing.
    Prasanna G, Ferrara L, Adams C, Ehara T, Li B, Yang L, Xiang C, Ng CTH, Kim S, Towler C, Topley T, McAllister C, Ghosh M, Newton R, Stacy R, Rice DS, Mogi M.
    Invest Ophthalmol Vis Sci; 2018 Apr 01; 59(5):1704-1716. PubMed ID: 29610853
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A, Sánchez M.
    Clin Ther; 2008 Jun 01; 30(6):1120-34. PubMed ID: 18640468
    [Abstract] [Full Text] [Related]

  • 31. Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol.
    Rácz P, Ruzsonyi MR, Nagy ZT, Gaygi Z, Bito LZ.
    Arch Ophthalmol; 1996 Mar 01; 114(3):268-73. PubMed ID: 8600885
    [Abstract] [Full Text] [Related]

  • 32. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG.
    J Glaucoma; 1999 Feb 01; 8(1):24-30. PubMed ID: 10084271
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group.
    Schuman JS, Horwitz B, Choplin NT, David R, Albracht D, Chen K.
    Arch Ophthalmol; 1997 Jul 01; 115(7):847-52. PubMed ID: 9230823
    [Abstract] [Full Text] [Related]

  • 37. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
    Easthope SE, Perry CM.
    Drugs Aging; 2002 Jul 01; 19(3):231-48. PubMed ID: 12027782
    [Abstract] [Full Text] [Related]

  • 38. Effect of topical timolol on optic nerve head circulation in the cynomolgus monkey.
    Ishii K, Araie M.
    Jpn J Ophthalmol; 2000 Jul 01; 44(6):630-3. PubMed ID: 11094178
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure.
    Liu JH, Kripke DF, Weinreb RN.
    Am J Ophthalmol; 2004 Sep 01; 138(3):389-95. PubMed ID: 15364220
    [Abstract] [Full Text] [Related]

  • 40. Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
    Weinreb RN, Scassellati Sforzolini B, Vittitow J, Liebmann J.
    Ophthalmology; 2016 May 01; 123(5):965-73. PubMed ID: 26875002
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.